NL7314765A - - Google Patents
Info
- Publication number
- NL7314765A NL7314765A NL7314765A NL7314765A NL7314765A NL 7314765 A NL7314765 A NL 7314765A NL 7314765 A NL7314765 A NL 7314765A NL 7314765 A NL7314765 A NL 7314765A NL 7314765 A NL7314765 A NL 7314765A
- Authority
- NL
- Netherlands
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2253317 | 1972-10-31 | ||
| DE2253318 | 1972-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7314765A true NL7314765A (de) | 1974-05-02 |
Family
ID=25764031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7314765A NL7314765A (de) | 1972-10-31 | 1973-10-26 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3883648A (de) |
| JP (1) | JPS5046821A (de) |
| AT (1) | AT341099B (de) |
| CA (1) | CA1004142A (de) |
| DE (1) | DE2355743A1 (de) |
| FR (1) | FR2204425B1 (de) |
| GB (1) | GB1445995A (de) |
| NL (1) | NL7314765A (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2966564D1 (en) * | 1978-11-20 | 1984-02-23 | American Home Prod | Therapeutic compositions with enhanced bioavailability and process for their preparation |
| US4344934A (en) * | 1978-11-20 | 1982-08-17 | American Home Products Corporation | Therapeutic compositions with enhanced bioavailability |
| FR2470599A1 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
| GB2118040A (en) * | 1982-02-15 | 1983-10-26 | Hoechst Uk Ltd | Oral anti-diabetic preparation |
| DE3320583A1 (de) * | 1983-06-08 | 1984-12-13 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung |
| DE3320582A1 (de) * | 1983-06-08 | 1984-12-13 | Dr. Karl Thomae Gmbh, 7950 Biberach | Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung |
| DE3325986C2 (de) * | 1983-07-19 | 1985-05-23 | Klinge Pharma GmbH, 8000 München | Schnell resorbierbare Zubereitung schwer löslicher Wirkstoffe |
| DE3326167A1 (de) * | 1983-07-20 | 1985-02-21 | Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim | Feste arzneiformen, die als wirkstoff n-4-(2-(5-chlor-2-methoxybenzamido)-ethyl)-phenylsulfonyl-n'-cyclohexylharnstoff enthalten und verfahren zu ihrer herstellung |
| KR870007114A (ko) * | 1986-01-21 | 1987-08-14 | 우에노 기미오 | 티올 에스테르 유도체의 안정된 고형제 |
| DE3833439A1 (de) * | 1988-10-01 | 1991-09-12 | Hoechst Ag | Verfahren zur mikronisierung von glibenclamid |
| EP1882414A1 (de) * | 2006-07-29 | 2008-01-30 | Bayer CropScience AG | Schmelzgranulate |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2875130A (en) * | 1956-11-20 | 1959-02-24 | Smith Kline French Lab | Method of preparing sustained release particles and the product of the method |
| US3146167A (en) * | 1961-10-05 | 1964-08-25 | Smith Kline French Lab | Method of preparing sustained release pellets and products thereof |
| US3361632A (en) * | 1964-05-08 | 1968-01-02 | Hoechst Ag | Medicinal preparations having a protracted activity and method of making them |
| DE1467938C3 (de) * | 1964-05-22 | 1973-12-20 | F. Hoffmann-La Roche & Co Ag, Basel (Schweiz) | Wasserdispergierbares Arzneipräparat für Tiere |
| FR1487897A (fr) * | 1965-07-27 | 1967-07-07 | Hoechst Ag | Benzène-sulfonyl-urées et leur préparation |
| US3374146A (en) * | 1966-04-18 | 1968-03-19 | American Cyanamid Co | Sustained release encapsulation |
| NL6808619A (de) * | 1968-06-19 | 1969-12-23 | ||
| NL7112288A (de) * | 1970-09-16 | 1972-03-20 | ||
| DE2055930A1 (de) * | 1970-11-13 | 1972-05-18 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verbesserte orale Applikationsform von Raubasin |
-
1973
- 1973-10-26 NL NL7314765A patent/NL7314765A/xx unknown
- 1973-10-29 US US410311A patent/US3883648A/en not_active Expired - Lifetime
- 1973-10-30 CA CA184,767A patent/CA1004142A/en not_active Expired
- 1973-10-30 AT AT916573A patent/AT341099B/de not_active IP Right Cessation
- 1973-10-31 GB GB5065373A patent/GB1445995A/en not_active Expired
- 1973-10-31 FR FR7338928A patent/FR2204425B1/fr not_active Expired
- 1973-10-31 JP JP48121878A patent/JPS5046821A/ja active Pending
- 1973-11-08 DE DE19732355743 patent/DE2355743A1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5046821A (de) | 1975-04-25 |
| DE2355743A1 (de) | 1975-05-22 |
| GB1445995A (en) | 1976-08-11 |
| FR2204425A1 (de) | 1974-05-24 |
| US3883648A (en) | 1975-05-13 |
| FR2204425B1 (de) | 1977-04-22 |
| ATA916573A (de) | 1977-05-15 |
| AT341099B (de) | 1978-01-25 |
| CA1004142A (en) | 1977-01-25 |